Amicus Therapeutics Inc $6.61

down -0.09


19/9/2014 04:00 PM  |  NASDAQ : FOLD  
Industries : Drugs / Biotechnology

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
8/27/2014SBLENDORIO GLENNDirector10,000$6.5083.80%
8/27/2014SBLENDORIO GLENNDirector-10,000$6.50-45.59%
8/27/2014Gershkowitz JayneVP, Patient Advocacy5,000$7.0010.00%
8/27/2014Gershkowitz JayneVP, Patient Advocacy-5,000$7.00-9.09%
8/25/2014Valenzano KenVP, Pharmacology & Biology7,450$6.0014.41%
8/25/2014Valenzano KenVP, Pharmacology & Biology5,000$6.008.45%
8/25/2014Valenzano KenVP, Pharmacology & Biology-12,450$6.00-19.41%
8/25/2014Gershkowitz JayneVP, Patient Advocacy-5,000$6.00-9.09%
8/25/2014Dilone EnriqueVP, Technical Operations7,000$6.0014.00%
8/25/2014Dilone EnriqueVP, Technical Operations-7,000$6.00-12.28%
8/25/2014Campbell Bradley LChief Operating Officer7,000$6.003.50%
8/25/2014Campbell Bradley LChief Operating Officer-7,000$6.00-3.38%
8/25/2014Gershkowitz JayneVP, Patient Advocacy5,000$6.0010.00%
8/20/2014Gershkowitz JayneVP, Patient Advocacy6,080$5.4012.16%
8/20/2014Valenzano KenVP, Pharmacology & Biology-7,000$5.40-11.92%
8/20/2014Valenzano KenVP, Pharmacology & Biology7,000$5.4013.54%
8/20/2014Campbell Bradley LChief Operating Officer18,750$5.409.38%
8/20/2014Gershkowitz JayneVP, Patient Advocacy-6,080$5.40-10.84%
8/20/2014Dilone EnriqueVP, Technical Operations5,000$5.4010.00%
8/20/2014Dilone EnriqueVP, Technical Operations7,810$5.4014.20%
8/20/2014Dilone EnriqueVP, Technical Operations-12,810$5.40-20.39%
8/20/2014Campbell Bradley LChief Operating Officer-18,750$5.40-8.57%
6/30/2014PERCEPTIVE ADVISORS LLCSubstantial Shareholder530,000$3.504.49%
6/30/2014PERCEPTIVE ADVISORS LLCSubstantial Shareholder3,470,000$3.5041.61%
6/27/2014Crowley John FChairman & CEO16,491$0.6417.81%
6/16/2014Crowley John FChairman & CEO25,000$2.6936.99%
5/12/2014Crowley John FChairman & CEO14,100$2.2226.36%
5/12/2014Crowley John FChairman & CEO900$2.211.71%
3/14/2014Crowley John FChairman & CEO10,000$2.2923.48%
3/14/2014Do HungSr Vice President Discovery-22,065$2.26-2.17%
3/12/2014Do HungSr Vice President Discovery-85,032$2.21-7.72%
3/12/2014Crowley John FChairman & CEO10,000$2.1630.68%
3/11/2014Do HungSr Vice President Discovery-121,642$2.22-9.94%
3/11/2014Crowley John FChairman & CEO17,108$2.21110.49%
3/10/2014Do HungSr Vice President Discovery-108,018$2.28-8.11%
3/07/2014Do HungSr Vice President Discovery-68,418$2.32-4.89%
12/13/2013Crowley John FChairman & CEO10,000$2.058.10%
11/25/2013Crowley John FChairman & CEO10,000$2.088.82%
11/20/2013GLAXOSMITHKLINE PLCSubstantial Shareholder1,500,000$2.0015.28%
3/15/2013Crowley John FChairman & CEO18,506$3.4919.50%
3/15/2013BARER SOL JDirector25,000$3.40125.00%
7/17/2012GLAXOSMITHKLINE PLCSubstantial Shareholder2,949,581$6.3042.96%
3/30/2012Crowley John FChairman & CEO49,931$0.64506.04%
3/07/2012BARRETT M JAMESSenior Executive Officer925,154$5.7025.28%
3/07/2012NEW ENTERPRISE ASSOCIATES 11 LPTenPercent925,154$5.7025.28%
3/07/2012BARRIS PETER JTenPercent214,846$5.7025.24%
3/07/2012BARRIS PETER JTenPercent925,154$5.7025.28%
3/07/2012KRAMLICH C RICHARDTenPercent214,846$5.7025.24%
3/07/2012KRAMLICH C RICHARDTenPercent925,154$5.7025.28%
3/07/2012NEWHALL CHARLES W IIITenPercent214,846$5.7025.24%
3/07/2012NEWHALL CHARLES W IIITenPercent925,154$5.7025.28%
3/07/2012PERRY MARK WTenPercent214,846$5.7025.24%
3/07/2012PERRY MARK WTenPercent925,154$5.7025.28%
8/11/2011Crowley John FChairman & CEO10,000$4.2010.01%
6/17/2011Crowley John FExecutive Chairman20,000$6.0425.04%
5/24/2011Valenzano KenVP, Pharmacology & Biology2,250$0.64131.73%
5/24/2011Valenzano KenVP, Pharmacology & Biology-2,250$7.50-56.85%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (FOLD), click here.
Trading Center